Atrial fibrillation (AF) and ischemic stroke are dual epidemics in society, both associated with
poor clinical outcomes, patient disability, and significant healthcare expenditure. The …

Abstract Background CHADS 2 and CHA 2 DS 2-VASc are validated scores used to predict
stroke in patients with atrial fibrillation. Many of the individual risk factors included in these …

Background Contemporary clinical risk stratification schemata for predicting stroke and
thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk …

Despite the demonstrable success of oral anticoagulants in reducing the rate of stroke in
patients with atrial fibrillation, they continue to be seriously underutilized. Indications for their …

The CHADS2 score predicts the risk of ischaemic stroke in patients with non-valvular atrial
fibrillation (NVAF). Most components of the CHADS 2 score are also risk factors of …

Background In patients at high risk of stroke, such as atrial fibrillation (AF), there has been
great interest in developing stroke risk prediction schemes for identifying those at high risk of …

The risk of stroke in patients with non-valvular atrial fibrillation (NVAF) varies widely
depending on patient age and the presence of other risk factors such as hypertension …

Background Patients with atrial fibrillation (AF) with CHA2DS2‐VASc score of 1 (where
CHA2DS2‐VASc is CHA2DS2‐Vascular disease, Age 65–74 years, Sex category) are …

Objectives To determine the accuracy of CHADS2 and CHA2DS2-VASc tools for predicting
ischaemic stroke or transient ischaemic attack (TIA) and death in patients without a history of …

Background: When assessing ischemic stroke risk in patients with atrial fibrillation (AF), the
CHA2DS2-VASc score is calculated based on the baseline risk factors, and the outcomes …